Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
Flint launched on October 21, 2026. It is a 40-billion-parameter model built specifically for coding work. On a MacBook Pro with an M4 Pro chip, Flint generates over 125 tokens per second. On RTX ...
Want only the AI that hits your stack? Build an agent that tracks your companies and topics, and skips everything else. Half a century after mathematicians modelled the recursion inside M.C. Escher's ...
Autonomous vehicles are often described as computers on wheels, but the phrase understates just how tangled the software inside them has become. A single self-driving stack must ingest torrents of ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Regan Peng is an AI founder and former senior tech executive, focused on personal AI, ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
This score calculates overall vulnerability severity from 0 to 10 and is based on the Common Vulnerability Scoring System (CVSS). Attack vector: More severe the more the remote (logically and ...
"issue": "Complete authentic signature did not validate attempt mapping/source version; wrong attempt could release A and admit B.", "resolution": "Independent ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results